Blue Enriched Versus Standard Light Treatment for Seasonal Affective Disorder(SAD)

NCT ID: NCT01048294

Last Updated: 2010-01-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

52 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-10-31

Study Completion Date

2006-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

One of the most frequently investigated hypothesis of the pathophysiology underlying Seasonal Affective Disorder(SAD) or so called winterdepression is a disturbance of circadian rhythms. Since the circadian system is especially sensitive for the blue portion of the light spectrum, a new light therapy device with more blue light (blue enriched polychromatic light) was tested for its efficacy to treat SAD. In chronobiological terms this light is hypothesized to be more potent in inducing non-visual effects. In the present study fluorescent tubes that emit a high portion of short wavelength light on top of the normal wavelengths are tested for its superiority in treating SAD. This blue-enriched light (colour temperature 17000 ºK) is compared to standard light treatment (5000 º K) in SAD patients., The investigators hypothesise that blue- enriched light improve the therapeutic effects of light treatment leading to a higher response or the same response in a shorter time schedule compared to standard light treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Seasonal Affective Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard Light Treatment

30 min of Standard bright light treatment (color 5000K)

Group Type ACTIVE_COMPARATOR

Original Energy Light,

Intervention Type DEVICE

9000 lux, 30 minutes in the morning

Blue enriched Light treatment 20 min

20 minutes of Blue enriched light treatment (color 17000K)

Group Type EXPERIMENTAL

Original Energy Light prototype

Intervention Type DEVICE

9000 lux 20 minutes in the morning

Blue enriched light treatment 30 min

30 minutes of Blue enriched light treatment (color 17000K)

Group Type EXPERIMENTAL

Original Energy Light prototype

Intervention Type DEVICE

9000 lux 30 minutes in the morning

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Original Energy Light,

9000 lux, 30 minutes in the morning

Intervention Type DEVICE

Original Energy Light prototype

9000 lux 20 minutes in the morning

Intervention Type DEVICE

Original Energy Light prototype

9000 lux 30 minutes in the morning

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Philips energy light HF 3308; 2 lamps PLL36W color 5000K Philips energy light HF 3308; 2 lamps PLL36W color 17000K Philips energy light HF 3308; 2 lamps PLL36W color 17000K

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 18-65;
* diagnosis of Seasonal affective Disorder, winter type according to DSM-IV;
* SIGH SAD rating higher then or equal to 18 on day 1;
* no other treatments for mood disorder during the study
* stay in the Netherlands during the study

Exclusion Criteria

* other Axis 1 disorder according to DSM-IV
* acute suicide risk
* use of psychotropic drugs or photosensitizing drugs
* eye diseases other then usual effect of aging
* diabetes or epilepsy
* regular shift work
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Medical Center Groningen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

University Medical Center Groningen

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Y. Meesters, PhD

Role: STUDY_CHAIR

Department of Psychiatry, University Medical Center Groningen, The Netherlands

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Psychiatry, University Medical Center Groningen

Groningen, , Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

References

Explore related publications, articles, or registry entries linked to this study.

Gordijn MCM, 't Mannetje D, Meesters Y. The effects of blue-enriched light treatment compared to standard light treatment in Seasonal Affective Disorder. J Affect Disord. 2012 Jan;136(1-2):72-80. doi: 10.1016/j.jad.2011.08.016. Epub 2011 Sep 10.

Reference Type DERIVED
PMID: 21911257 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

METc2005/160

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Light Therapy for Elderly Depression
NCT00332670 TERMINATED PHASE2/PHASE3
Impact of Light on Mood
NCT06027944 UNKNOWN NA